The store will not work correctly when cookies are disabled.
N-(6-(3-chlorophenyl)pyridazin-3-yl)pyridine-2-sulfonamide
ID: ALA4794620
PubChem CID: 162672387
Max Phase: Preclinical
Molecular Formula: C15H11ClN4O2S
Molecular Weight: 346.80
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1ccc(-c2cccc(Cl)c2)nn1)c1ccccn1
Standard InChI: InChI=1S/C15H11ClN4O2S/c16-12-5-3-4-11(10-12)13-7-8-14(19-18-13)20-23(21,22)15-6-1-2-9-17-15/h1-10H,(H,19,20)
Standard InChI Key: NZFDMBVAWJNTAZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
42.1927 -19.0224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.7882 -18.3166 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.3792 -19.0198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.9596 -18.3290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9585 -19.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6665 -19.5575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3762 -19.1480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3734 -18.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6647 -17.9201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.2523 -19.5568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5447 -19.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8371 -19.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8360 -20.3714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5484 -20.7804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2530 -20.3707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1299 -19.1438 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
41.0795 -17.9141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4949 -17.9088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2026 -18.3181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9083 -17.9075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9056 -17.0895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1914 -16.6837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4887 -17.0966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
5 10 1 0
12 16 1 0
8 17 1 0
17 2 1 0
2 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.80 | Molecular Weight (Monoisotopic): 346.0291 | AlogP: 2.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.84 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.28 | CX Basic pKa: ┄ | CX LogP: 2.87 | CX LogD: 1.95 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.78 | Np Likeness Score: -2.02 |
References
1. Kimura H,Suda H,Kassai M,Endo M,Deai Y,Yahata M,Miyajima M,Isobe Y. (2021) N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors., 33 [PMID:33359168] [10.1016/j.bmcl.2020.127753] |